BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

418 related articles for article (PubMed ID: 21294120)

  • 21. Transcriptional expression profiles of oral squamous cell carcinomas.
    Méndez E; Cheng C; Farwell DG; Ricks S; Agoff SN; Futran ND; Weymuller EA; Maronian NC; Zhao LP; Chen C
    Cancer; 2002 Oct; 95(7):1482-94. PubMed ID: 12237917
    [TBL] [Abstract][Full Text] [Related]  

  • 22. p53, p21 and p27 protein expression in head and neck cancer and their prognostic value.
    Kapranos N; Stathopoulos GP; Manolopoulos L; Kokka E; Papadimitriou C; Bibas A; Yiotakis J; Adamopoulos G
    Anticancer Res; 2001; 21(1B):521-8. PubMed ID: 11299798
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stromelysin 3, Ets-1, and vascular endothelial growth factor expression in oral precancerous and cancerous lesions: correlation with microvessel density, progression, and prognosis.
    Arora S; Kaur J; Sharma C; Mathur M; Bahadur S; Shukla NK; Deo SV; Ralhan R
    Clin Cancer Res; 2005 Mar; 11(6):2272-84. PubMed ID: 15788677
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oral squamous cell carcinoma: status of tight junction claudins in the different histopathological patterns and relationship with clinical parameters. A tissue-microarray-based study of 136 cases.
    Lourenço SV; Coutinho-Camillo CM; Buim ME; Pereira CM; Carvalho AL; Kowalski LP; Soares FA
    J Clin Pathol; 2010 Jul; 63(7):609-14. PubMed ID: 20591911
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Plasminogen activator inhibitor-2: a molecular biomarker for head and neck cancer progression.
    Hasina R; Hulett K; Bicciato S; Di Bello C; Petruzzelli GJ; Lingen MW
    Cancer Res; 2003 Feb; 63(3):555-9. PubMed ID: 12566295
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Loss of 14-3-3 sigma protein expression and presence of human papillomavirus type 16 E6 in oral squamous cell carcinoma.
    Bhawal UK; Sugiyama M; Nomura Y; Kuniyasu H; Tsukinoki K
    Arch Otolaryngol Head Neck Surg; 2008 Oct; 134(10):1055-9. PubMed ID: 18936350
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dominant negative p63 isoform expression in head and neck squamous cell carcinoma.
    Sniezek JC; Matheny KE; Westfall MD; Pietenpol JA
    Laryngoscope; 2004 Dec; 114(12):2063-72. PubMed ID: 15564824
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Altered p16INK4a and Fhit expression in carcinogenesis and progression of human oral cancer.
    Paradiso A; Ranieri G; Stea B; Zito A; Zehbe I; Tommasino M; Grammatica L; De Lena M
    Int J Oncol; 2004 Feb; 24(2):249-55. PubMed ID: 14719099
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Overexpression of p53 is an early event in the tumorigenesis of oral squamous cell carcinomas.
    Shintani S; Yoshihama Y; Emilio AR; Matsumura T
    Anticancer Res; 1995; 15(2):305-8. PubMed ID: 7762998
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Illumina whole-genome complementary DNA-mediated annealing, selection, extension and ligation platform: assessing its performance in formalin-fixed, paraffin-embedded samples and identifying invasion pattern-related genes in oral squamous cell carcinoma.
    Loudig O; Brandwein-Gensler M; Kim RS; Lin J; Isayeva T; Liu C; Segall JE; Kenny PA; Prystowsky MB
    Hum Pathol; 2011 Dec; 42(12):1911-22. PubMed ID: 21683979
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular profiling of tumor progression in head and neck cancer.
    Belbin TJ; Singh B; Smith RV; Socci ND; Wreesmann VB; Sanchez-Carbayo M; Masterson J; Patel S; Cordon-Cardo C; Prystowsky MB; Childs G
    Arch Otolaryngol Head Neck Surg; 2005 Jan; 131(1):10-8. PubMed ID: 15655179
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of multi-drug resistance genes (mdr1, mrp1, bcrp) in primary oral squamous cell carcinoma.
    Friedrich RE; Punke C; Reymann A
    In Vivo; 2004; 18(2):133-47. PubMed ID: 15113040
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Overexpression of activin A in oral squamous cell carcinoma: association with poor prognosis and tumor progression.
    Chang KP; Kao HK; Liang Y; Cheng MH; Chang YL; Liu SC; Lin YC; Ko TY; Lee YS; Tsai CL; Wang TH; Hao SP; Tsai CN
    Ann Surg Oncol; 2010 Jul; 17(7):1945-56. PubMed ID: 20309641
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential expression of matrilysin-1 (MMP-7), 92 kD gelatinase (MMP-9), and metalloelastase (MMP-12) in oral verrucous and squamous cell cancer.
    Impola U; Uitto VJ; Hietanen J; Hakkinen L; Zhang L; Larjava H; Isaka K; Saarialho-Kere U
    J Pathol; 2004 Jan; 202(1):14-22. PubMed ID: 14694517
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of TP53 in the progression of pre-malignant and malignant oral mucosal lesions. A follow-up study of 144 patients.
    Ogmundsdóttir HM; Björnsson J; Holbrook WP
    J Oral Pathol Med; 2009 Aug; 38(7):565-71. PubMed ID: 19473450
    [TBL] [Abstract][Full Text] [Related]  

  • 36. p73 expression for human buccal epithelial dysplasia and squamous cell carcinoma: does it correlate with nodal status of carcinoma and is there a relationship with malignant change of epithelial dysplasia?
    Chen YK; Hsue SS; Lin LM
    Head Neck; 2004 Nov; 26(11):945-52. PubMed ID: 15390192
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A lymph node metastatic mouse model reveals alterations of metastasis-related gene expression in metastatic human oral carcinoma sublines selected from a poorly metastatic parental cell line.
    Zhang X; Liu Y; Gilcrease MZ; Yuan XH; Clayman GL; Adler-Storthz K; Chen Z
    Cancer; 2002 Oct; 95(8):1663-72. PubMed ID: 12365014
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gene expression signatures that can discriminate oral leukoplakia subtypes and squamous cell carcinoma.
    Kondoh N; Ohkura S; Arai M; Hada A; Ishikawa T; Yamazaki Y; Shindoh M; Takahashi M; Kitagawa Y; Matsubara O; Yamamoto M
    Oral Oncol; 2007 May; 43(5):455-62. PubMed ID: 16979924
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Skp2 is oncogenic and overexpressed in human cancers.
    Gstaiger M; Jordan R; Lim M; Catzavelos C; Mestan J; Slingerland J; Krek W
    Proc Natl Acad Sci U S A; 2001 Apr; 98(9):5043-8. PubMed ID: 11309491
    [TBL] [Abstract][Full Text] [Related]  

  • 40. DeltaNp63 isoforms regulate CD44 and keratins 4, 6, 14 and 19 in squamous cell carcinoma of head and neck.
    Boldrup L; Coates PJ; Gu X; Nylander K
    J Pathol; 2007 Dec; 213(4):384-91. PubMed ID: 17935121
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.